Beta-adrenoblockers in arterial hypertension treatment: focus on nebivolol

QR Code

Beta-adrenoblockers in arterial hypertension treatment: focus on nebivolol

.

Saved in:

Bibliographic Details
Main Authors:	D. Voytsekhovsky, V. Papademetrio
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2008-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1585
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beta-adrenoblocker nebivolol in the new Russian guidelines on arterial hypertension
by: L. G. Ratova, et al.
Published: (2008-08-01)

NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER
by: T. Műnzel, et al.
Published: (2016-01-01)

Effective treatment with cardioselective beta-adrenoblocker nebivolol in patients with arterial hypertension and broncho-obstructive syndrome
by: S. I. Ovcharenko, et al.
Published: (2007-08-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01)

Superselective beta-adrenoblocker Nebivolol in patients with cardiovascular pathology and obstructive pulmonary syndrome
by: S. I. Ovcharenko, et al.
Published: (2006-04-01)

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
by: L. L. Kirichenko, et al.
Published: (2006-12-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

BETA-ADRENOBLOCKERS IN THE MODERN MANAGEMENT OF ARTERIAL HYPERTENSION. BISOPROLOL EFFECTIVENESS AND TOLERABILITY
by: N. A. Dmitrieva
Published: (2009-10-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

HIGHLY SELECTIVE BETA-ADRENOBLOCKER BISOPROLOL IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND ASSOCIATED CLINICAL CONDITIONS
by: A. N. Britov
Published: (2011-08-01)

BETA-ADRENOBLOCKER THERAPY IN ARTERIAL HYPERTENSION, METABOLIC DISTURBANCES, AND TYPE 2 DIABETES MELLITUS
by: D. V. Nebieridze, et al.
Published: (2009-08-01)

BETA-ADRENOBLOCKERS IN HEART FAILURE TREATMENT
by: M. A. Gurevich
Published: (2009-02-01)

ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01)

BETA-ADRENOBLOCKERS IN LONG-TERM MONOTHERAPY AMONG PATIENTS WITH ARTERIAL HYPERTENSION: EFFECTS ON QUALITY OF LIFE AND TREATMENT COMPLIANCE
by: F. Z. Kasumova
Published: (2010-10-01)

Beta-adrenoblockers in cardiology practice
by: A. A. Garganeeva
Published: (2010-10-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Beta-adrenoblockers in patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-04-01)

Beta-adrenoblockers: treatment principles in international clinical guidelines
by: S. Yu. Martsevich
Published: (2005-08-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol
by: T. D. Giles
Published: (2011-12-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Pathogenetic therapy of heart failure: beta-adrenoblockers
by: O. Yu. Shayduk, et al.
Published: (2012-12-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Nebivolol influence on cardiovascular system and kidneys in post-partum arterial hypertension
by: A. L. Vertkin, et al.
Published: (2005-04-01)

EVALUATION OF BETA-ADRENOBLOCKERS TREATMENT IN CARDIOVASCULAR DISEASES COMORBID WITH DIABETES IN OUTPATIENT SETTING
by: N. A. Komkova, et al.
Published: (2017-12-01)

Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
by: V. N. Larina, et al.
Published: (2021-11-01)

Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Beta-adrenoblocker therapy in patients with severe chronic heart failure
by: I. I. Sinitsyna, et al.
Published: (2007-02-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016-01-01)

Platelet aggregation activity and beta-adrenoblocker therapy in patients with dilated cardiomyopathy
by: P. N. Isakhanova, et al.
Published: (2012-02-01)

Angioprotection role in arterial hypertension treatment: focus on olmesartan
by: D. V. Nebieridze, et al.
Published: (2012-10-01)

EFFICACY AND SAFETY OF BETA-ADRENOBLOCKER TREATMENT DURING POSTOPERATIONAL PERIOD AFTER EXTRACARDIAL SURGERY - A PARADIGM SHIFT?
by: Yu. V. Shchukin, et al.
Published: (2014-09-01)

Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved?
by: Yu. M. Lopatin
Published: (2009-12-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)